Guidelines for the diagnosis and treatment of incomplete Kawasaki disease

Title: Guidelines for the diagnosis and treatment of incomplete Kawasaki disease
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: Use of this consensus includes all pediatric rheumatology and pediatric cardiovascular physicians and general practitioners.
Evidence classification method: Evidence grading method: The evidence recommendation grading evaluation, formulation and evaluation method (GRADE) was used to determine the recommendation level of a clinical issue in this consensus according to the credibility level of literature or data under the guidance of the GRADE manual.
Development unit: Formulated by: Children's Hospital of Shaanxi Provincial People's Hospital; Beijing Children's Hospital, Shanghai Children's Hospital, Chinese Journal of Contemporary Pediatrics, , Guangzhou Women and Children's Medical Center, The First Hospital of Jilin University, the Provincial Hospital Affiliated to Shandong First Medical University, Sichuan Academy of Medical Sciences (Sichuan Provincial People's Hospital), Sichuan Maternal and Child Health Care Hospital, Children's Hospital Affiliated to Nanjing Medical University, Hunan Children's Hospital, Ningxia Medical University General Hospital, Fujian Provincial Hospital, Shaanxi Kawasaki Disease Diagnosis and Treatment Center
Registration time: 2023-04-05
Registration number: PREPARE-2023CN243
Purpose of the guideline: Purpose of the guideline: To standardize the clinical diagnosis and treatment of incomplete Kawasaki disease, and guide the clinical diagnosis, treatment and research of incomplete Kawasaki disease for clinical pediatric medical staff. In particular, to standardize and guide the diagnosis and treatment of incomplete Kawasaki disease and coronary artery lesion , and to unify the diagnosis and treatment methods and standards.